Sign in
4/A

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0000899243-19-004317

Chairman sold 20,832 shares at $69.59 ($1,449,699)

  • Chairman acquired 81,005 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

El-Hibri Fuad · Chairman

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2018-11-19 Exercise or conversion : show line 1 in the form +20,000 $14.44 $288,800 1,508,675 D
2018-11-20 Exercise or conversion : show line 2 in the form +15,173 $14.44 $219,098 1,503,848 D
2018-11-26 Exercise or conversion : show line 3 in the form +25,000 $13.38 $334,500 1,513,675 D
2018-11-27 Exercise or conversion : show line 4 in the form +20,832 $13.38 $278,732 1,509,507 D
2018-11-27 Sale : show line 5 in the form −20,832 $69.59 $1,449,699 1,488,675 D
Open-market sales · 20,832 sh · avg $69.59 · $1,449,699

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2018-11-19 Exercise or conversion : show line 6 in the form Employee Stock Options (Right to Buy) −20,000 15,173 D
2018-11-20 Exercise or conversion : show line 7 in the form Employee Stock Options (Right to Buy) −15,173 0 D
2018-11-26 Exercise or conversion : show line 8 in the form Employee Stock Options (Right to Buy) −25,000 20,832 D
2018-11-27 Exercise or conversion : show line 9 in the form Employee Stock Options (Right to Buy) −20,832 0 D
Loading xslF345X03/doc4a.xml…